“…Similar to vaccine candidates for human use, several NDV vaccines expressing multiple antigens have been developed for veterinary use either by co-expressing the antigens within the same vector [ 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 ] or by inoculating different vectors, each expressing a different antigen, in the same formulation [ 71 , 86 , 93 , 94 ]. For the latter, two studies have found that a formulation with only one vector/antigen yielded better results and sufficient protection [ 86 , 93 ], while another study found adequate immune responses regardless of inoculating one or multiple vectors [ 71 ].…”